Dr. Keith Jarvi: Improving men’s health
“The PSI funding was essential in allowing us to initiate our work on semen proteomics: this understanding of semen proteins was subsequently used as the basis for the work we have done to identify novel semen biomarkers for different types of infertility, prostate cancer and chronic pelvic pain in men. This resulting work has now been supported by CIHR, CCSRI, The Canadian Urology Association, bioMerieux Laboratory, LabCorp USA and MaRS Innovation. None of this would have been possible without that initial support from PSI.”
PSI Foundation funded Dr. Keith Jarvi of Mount Sinai Hospital in Toronto for his study Use of Seminal Fluid Protein Patterns as Biomarkers for Diseases in the Male Reproductive Tract: Prediction of Spermatogenesis in Men with Azoospermia. In 2007, PSI approved $158,000 for his 2 year study.
Dr. Jarvi is a Professor in the Department of Surgery at the University of Toronto. He is also the Director of the Murray Koffler Urologic Wellness Centre and Head of Urology at Mount Sinai Hospital.
Dr. Jarvi has had several papers resulting from this research, with the most recent being published in Science Translational Medicine. This study has also been featured in media including the Toronto Star, the Globe and Mail, and BBC Health News.